Er-Kim has signed an agreement with Sentynl Therapeutics to distribute [...]

DEBRA Research gGmbH, a global non-profit dedicated to advancing research [...]

CureDuchenne will host CureDuchenne Fuerza 2025, a one-day educational and [...]

Poolbeg Pharma has appointed Accelerating Clinical Trials (ACT) to run [...]

Servier has acquired KER-0193 from Kaerus Bioscience, gaining a potential [...]

Barcelona-based biotech advances Huntington’s programme as EMA backs orphan designation, [...]

Telix Pharmaceuticals has reached agreement with the US Food and [...]

Amorphical has appointed Eden Ben as chief executive officer, as [...]

NRG Therapeutics Ltd, a neuroscience company developing treatments targeting mitochondrial [...]

Protagonist Therapeutics has announced that the US Food and Drug [...]